NEW WHITE PAPER:  Solving Atypical Protein Expression with Transposase Technology    Dive in today!
Contact Us
Contact Us

AGC Biologics

2 min read

AGC Biologics Lands Commercial Manufacturing Agreement for Yokohama Site Worth Hundreds of Millions of Dollars

July 28, 2026 at 6:00 AM
Mammalian & mAbs Press Release Business Updates
Read press release

2 min read

AGC Biologics Expands to Fill-Finish in U.S. Through Strategic Partnership with Pyramid Pharma Services

June 30, 2026 at 9:00 AM
Mammalian & mAbs Press Release Business Updates Microbial
Read press release

2 min read

AGC Biologics to Manufacture Teikoku Seiyaku's rhMMP-7 Drug Substance

May 25, 2026 at 5:00 PM
Press Release Tech Transfer Microbial
Read press release
Logos of AGC Bio and Orphan Therapeutics shown to reflect new network partnership

2 min read

AGC Biologics Joins Orphan Therapeutics Accelerator’s Clinical Development Network as a Manufacturing Partner to Advance Cell and Gene Therapies for Ultra-Rare Diseases

May 11, 2026 at 5:00 AM
Cell & Gene Therapy Press Release
Read press release
AGC Biologics and Novelty Nobility leaders meet to discuss GMP manufacturing of bispecific drug candidate, NN4101 in Tokyo, Japan on April 13, 2026.

2 min read

Novelty Nobility Taps AGC Biologics to Further Develop Bispecific Drug Candidate

May 3, 2026 at 4:45 PM
Mammalian & mAbs Press Release Cell Line Development
Read press release
Image showing award logo

3 min read

AGC Biologics Wins 2026 Fierce Outsourcing Award for Leadership in Regulatory and Quality Compliance

April 27, 2026 at 8:30 AM
Read press release

2 min read

AGC Biologics Seattle site now certified to manufacture biologics for largest pharmaceutical market in South America

February 3, 2026 at 8:00 AM
Mammalian & mAbs Press Release Business Updates Microbial
Read press release
AGC Biologics and Fondazione Telethon celebrate regulatory approvals for gene therapy

3 min read

AGC Biologics Celebrates U.S. and EU Approval of Fondazione Telethon’s Waskyra™ Treatment for Wiskott-Aldrich Syndrome

January 16, 2026 at 11:00 AM
Cell & Gene Therapy Press Release
Read press release

2 min read

Asimov and AGC Biologics Team Up to Provide a Cost-Effective, Simplified, and Secure Manufacturing Approach for Viral Vector Production

January 12, 2026 at 4:00 AM
Cell & Gene Therapy Press Release Business Updates
Read press release

3 min read

AGC Biologics Partners with ATUM to Accelerate Timelines for Cell Line Development

December 2, 2025 at 6:00 AM
Mammalian & mAbs Press Release Business Updates Cell Line Development
Read press release
1 2 3 4 5 Next